Product NDC: | 66435-201 |
Proprietary Name: | Infergen |
Non Proprietary Name: | Interferon alfacon-1 |
Active Ingredient(s): | .03 mg/mL & nbsp; Interferon alfacon-1 |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66435-201 |
Labeler Name: | Kadmon Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103663 |
Marketing Category: | BLA |
Start Marketing Date: | 19971006 |
Package NDC: | 66435-201-15 |
Package Description: | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (66435-201-15) > .5 mL in 1 VIAL, SINGLE-DOSE (66435-201-96) |
NDC Code | 66435-201-15 |
Proprietary Name | Infergen |
Package Description | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (66435-201-15) > .5 mL in 1 VIAL, SINGLE-DOSE (66435-201-96) |
Product NDC | 66435-201 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Interferon alfacon-1 |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 19971006 |
Marketing Category Name | BLA |
Labeler Name | Kadmon Pharmaceuticals, LLC |
Substance Name | INTERFERON ALFACON-1 |
Strength Number | .03 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Interferon alpha [EPC],Interferon-alpha [Chemical/Ingredient] |